233 related articles for article (PubMed ID: 17917540)
41. Demographic and clinical properties of juvenile-onset Behçet's disease: A controlled multicenter study.
Karincaoglu Y; Borlu M; Toker SC; Akman A; Onder M; Gunasti S; Usta A; Kandi B; Durusoy C; Seyhan M; Utas S; Saricaoglu H; Ozden MG; Uzun S; Tursen U; Cicek D; Donmez L; Alpsoy E
J Am Acad Dermatol; 2008 Apr; 58(4):579-84. PubMed ID: 18045733
[TBL] [Abstract][Full Text] [Related]
42. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
[TBL] [Abstract][Full Text] [Related]
43. Genetic susceptibility to systemic sclerosis from clinical aspect to genetic factor analyses.
Granel B; Bernard F; Chevillard C
Eur J Intern Med; 2009 May; 20(3):242-52. PubMed ID: 19393491
[TBL] [Abstract][Full Text] [Related]
44. Nursing problems of patients with systemic sclerosis.
Sierakowska M; Sierakowski S; Lewko J; Jankowiak B; Kowalczuk K; Krajewska-Kułak E
Adv Med Sci; 2007; 52 Suppl 1():147-52. PubMed ID: 18232102
[TBL] [Abstract][Full Text] [Related]
45. New developments in localized scleroderma.
Zulian F
Curr Opin Rheumatol; 2008 Sep; 20(5):601-7. PubMed ID: 18698185
[TBL] [Abstract][Full Text] [Related]
46. [The evolution of juvenile systemic scleroderma].
Starovoĭtova MN; Guseva NG
Ter Arkh; 1997; 69(11):55-60. PubMed ID: 9483750
[TBL] [Abstract][Full Text] [Related]
47. Antiphospholipid syndrome in pediatrics.
Ravelli A; Martini A
Rheum Dis Clin North Am; 2007 Aug; 33(3):499-523. PubMed ID: 17936175
[TBL] [Abstract][Full Text] [Related]
48. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
Abou-Raya A; Abou-Raya S; Helmii M
J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
[TBL] [Abstract][Full Text] [Related]
49. Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes.
Papolos D; Mattis S; Golshan S; Molay F
J Affect Disord; 2009 Nov; 118(1-3):28-38. PubMed ID: 19631388
[TBL] [Abstract][Full Text] [Related]
50. Localized scleroderma and systemic sclerosis: is there a connection?
Gupta RA; Fiorentino D
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1025-36. PubMed ID: 18068859
[TBL] [Abstract][Full Text] [Related]
51. [Classification of systemic progressive sclerosis].
Reumatizam; 1996; 43(1):25-7. PubMed ID: 8966376
[No Abstract] [Full Text] [Related]
52. Estimating the burden of scleroderma disease in Spain.
Villaverde-Hueso A; Sánchez-Valle E; Alvarez E; Morant C; Carreira PE; Martín-Arribas MC; Gènova R; Ramírez-González A; de la Paz MP
J Rheumatol; 2007 Nov; 34(11):2236-42. PubMed ID: 17918783
[TBL] [Abstract][Full Text] [Related]
53. New ACR EULAR guidelines for systemic sclerosis classification.
Johnson SR
Curr Rheumatol Rep; 2015 May; 17(5):32. PubMed ID: 25874345
[TBL] [Abstract][Full Text] [Related]
54. Preliminary criteria for the classification of systemic sclerosis (scleroderma).
Bull Rheum Dis; 1981; 31(1):1-6. PubMed ID: 7459513
[No Abstract] [Full Text] [Related]
55. Review for best practice in clinical rheumatology juvenile systemic sclerosis - Updates and practice points.
Foeldvari I; Torok KS
Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101688. PubMed ID: 33896752
[TBL] [Abstract][Full Text] [Related]
56. Interstitial lung disease as the first manifestation of systemic sclerosis.
van der Kamp R; Tak PP; Jansen HM; Bresser P
Neth J Med; 2007 Nov; 65(10):390-4. PubMed ID: 18057462
[TBL] [Abstract][Full Text] [Related]
57. Aerobic exercise is safe and effective in systemic sclerosis.
Oliveira NC; dos Santos Sabbag LM; de Sá Pinto AL; Borges CL; Lima FR
Int J Sports Med; 2009 Oct; 30(10):728-32. PubMed ID: 19642060
[TBL] [Abstract][Full Text] [Related]
58. Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis.
Rose RF; Turner D; Goodfield MJ; Goulden V
Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):153-5. PubMed ID: 19438995
[TBL] [Abstract][Full Text] [Related]
59. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
[TBL] [Abstract][Full Text] [Related]
60. Clinical features of juvenile lupus erythematosus in Iranian children.
Moradinejad MH; Zamani GR; Kiani AR; Esfahani T
Acta Reumatol Port; 2008; 33(1):63-7. PubMed ID: 18344923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
